SELECTION OF COMBINATION OF AN ACE INHIBITORS AND DIURETICS IN THE TREATMENT OF HYPERTENSION IN THE NEW VERSION OF RUSSIAN RECOMMENDATIONS: FOCUS ON THE TREATMENT OF ELDERLY PATIENTS


Cite item

Full Text

Abstract

The article stated the possible indications for the choice of two-component combinations of antihypertensives, including ACE inhibitor with thiazide diuretics. The advantages of the combination of an ACE inhibitor with a diuretic in terms of antihypertensive efficacy, organoprotection, and metabolic neutrality are presented. Clinical aspects of a combination of an ACE inhibitor with a thiazide diuretic, its possible side effects and ways to their minimization are discussed. Particular attention is paid to the importance of treatment of arterial hypertension in elderly patients with polypathia (comorbidity), isolated systolic hypertension, as well as the choice of an ACE inhibitor in these conditions.

References

  1. Диагностика и лечение артериальной гипертензии. Российские рекомендации 2008 г. (3-й пересмотр) // Приложение 2 к журналу "Кардиоваскулярная терапия и профилактика". 2008;7(6).
  2. Руководство по артериальной гипертонии / Под ред. Е.И. Чазова, И.Е. Чазовой. М., 2005. С. 655-677.
  3. ESH-ESC Guidelines Committee. 2007 guidelines for the management of arterial hypertension. J Hypertension 2007;25:1105-87.
  4. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report. Hypertension 2003;42:1206-52.
  5. Чазова И.Е., Ратова Л.Г. Комбинированная терапия артериальной гипертонии. М., 2007. 183 с.
  6. Johnson BF. The emerging problem of plasma lipid changes during antihypertensive therapy. J Cardiovasc Pharmacol 1982;4:213-21.
  7. Chrysant SG. The Lisinopril-Hydrochlorthiazide Group. Antihypertensive effectiveness of low-dose hydrochlorthiazide combination. A large multicentral study. Arch Intern Med 1994;154:737-43.
  8. Antonios TF, Cappuccio FP, Markandu ND, et al. A diuretic is more effective than a beta-blocker in hypertensive patients non controlled on amlodipine and lisinopril. Hypertension 1996;27:1325-28.
  9. Чазова И.Е., Ратова Л.Г. и др. КЛИП-АККОРД: полнодозовая фиксированная комбинация в лечении 6346 пациентов с артериальной гипертонией // Болезни сердца и сосудов. 2006. № 3. С. 25-30.
  10. Беленков Ю.Н., Чазова И.Е., Ратова Л.Г. и др. Оценка эффективности моэксиприла у больных мягкой и умеренной артериальной гипертонией с гипертрофией миокарда левого желудочка (исследование ЭНИГМА) // Системные гипертензии 2005. № 1. С. 22-25.
  11. Pool JL, CushmanWC, Saini RK, et al. Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorthiazide combination therapy in hypertension. Am J Hypertens 1997;10:117-23.
  12. Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randimised controlled trial. Lancet 2007;370:829-40.
  13. Чазова И.Е., Ратова Л.Г., Колос И.П. и др. Нефропротекция в лечении больных артериальной гипертонией (результаты исследования ИРИС) // Системные гипертензии. 2005. № 1. С. 3-6.
  14. Sommers SC, Melarmed J. Renal pathology of essential hypertension. Am J Hypertens 1990;3(7):583-87.
  15. Оганов Р.Г. Профилактическая кардиология: от гипотез к практике // Кардиология. 1999. № 2. С. 4-9.
  16. Чазова И.Е., Бойцов С.А., Небиеридзе Д.В. Основные положения проекта второго пересмотра рекомендаций ВНОК по профилактике, диагностике и лечению артериальной гипертензии // Кардиваскулярная терапия и профилактика. 2004. № 4. С. 90-98.
  17. Barker DJP. Fetal origins of coronary heart disease. BMJ 1995;311:171-74.
  18. Newman DL, Lallemand RC. The effect of age on the distensibility of the abdominal aorta in man. Surg Gynecol Obstet 1978;147:211-14.
  19. Mohiaddin RH, Schoser , Amanuma M. MR imaging of age-related dimensional changes of thoratic aorta. J Comput Assist Tomogr 1990;14:748-52.
  20. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 1991;18:67-71.
  21. Vanhoutte PM. Aging and endothelial dysfunction. European Heart Journal 2002;(Suppl. A):A8-A17.
  22. Amery A, Brixko P, Clement D. Mortality and morbidity results from the European Working Party in High Blood Pressure in the Elderly trial. Lancet 1985;1349:54-62.
  23. Burt VL, Whelton P, Roccella EJ. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-91. Hypertension 1995;25:305-313.
  24. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertension 1999;17(Suppl. 2):7-13.
  25. MRC Working Party. Medical Researth Council trial of treatment of hypertension in older patients. BMJ 1992;304:405-12.
  26. Клиническая фармакология / Под ред. В.Г. Кукеса. Издание 4. М., 2008. С. 392-395.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies